Minjun Liao
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Co-authors
- Weijia Liao (14 shared papers)Yan Liao (4 shared papers)Weiwei Luo (1 shared paper)Yuanping Zhou (5 shared papers)Chunyan Huang (1 shared paper)Yongyuan Zhang (3 shared papers)Wei Dang (3 shared papers)Zhaoquan Huang (3 shared papers)
- Journals
- Cancer Management and Research (2 papers)Frontiers in Immunology (2 papers)Frontiers in Oncology (2 papers)OncoTargets and Therapy (1 paper)International Journal of Nanomedicine (1 paper)
- Partner nations
- ChinaOmanSwitzerland
In The Last Decade
Minjun Liao
20 papers receiving 285 citations
Peers
Comparison fields: 5 of 46
- Hepatology 66
- Cancer Research 40
- Oncology 43
- Cell Biology 24
- Immunology 26
Countries citing papers authored by Minjun Liao
This map shows the geographic impact of Minjun Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjun Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjun Liao more than expected).
Fields of papers citing papers by Minjun Liao
This network shows the impact of papers produced by Minjun Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjun Liao. The network helps show where Minjun Liao may publish in the future.
Co-authors
The 25 scholars most cited alongside Minjun Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 49 | |
| 2 | 2023 | 30 | |
| 3 | 2023 | 21 | |
| 4 | 2021 | 20 | |
| 5 | 2018 | 20 | |
| 6 | 2022 | 17 | |
| 7 | 2021 | 16 | |
| 8 | 2018 | 14 | |
| 9 | 2017 | 14 | |
| 10 | 2023 | 11 | |
| 11 | 2019 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2024 | 9 | |
| 15 | 2019 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2024 | 4 | |
| 19 | 2020 | 4 | |
| 20 | 2021 | 3 |
About Minjun Liao
Minjun Liao is a scholar working on Oncology, Hepatology, Molecular Biology, Epidemiology and Surgery, having authored 23 papers that have together received 285 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Coenzyme Q10 studies and effects (2 papers), Hepatitis B Virus Studies (2 papers), RNA modifications and cancer (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Hepatology (66 citations), Cancer Research (40 citations), Oncology (43 citations), Cell Biology (24 citations) and Immunology (26 citations). Minjun Liao has collaborated with scholars based in China, Oman and Switzerland. Frequent co-authors include Weijia Liao, Yan Liao, Weiwei Luo, Yuanping Zhou, Chunyan Huang, Yongyuan Zhang, Wei Dang, Zhaoquan Huang, Jun Li and Jun Li. Their work appears in journals such as Cancer Management and Research, Frontiers in Immunology, Frontiers in Oncology, OncoTargets and Therapy and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.